The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Pharmacology of Medical Cannabis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures
Story, G. M., Peier, A. M., Reeve, A. J., Eid, S. R., Mosbacher, J., Hricik, T. R., Earley, T. J., Hergarden, A. C., Andersson, D. A., Hwang, S. W., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00158-2 · Cited by 2,486
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Human Cannabinoid Pharmacokinetics
Huestis, M. A. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790152 · Cited by 1,102
Phytocannabinoids: a unified critical inventory
Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2016) · Natural Product Reports · doi:10.1039/c6np00074f · Cited by 844
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 783
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus
Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., Kelsch, W., Jacob, W., Marsch, R., Ekker, M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.006 · Cited by 706
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Crystal Structure of the Human Cannabinoid Receptor CB1
Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.004 · Cited by 673
Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.004 · Cited by 669
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 568
Huestis, M. A., Henningfield, J. E., & Cone, E. J. (1992) · Journal of Analytical Toxicology · doi:10.1093/jat/16.5.276 · Cited by 519
Mechoulam, R. (1970) · Science · doi:10.1126/science.168.3936.1159 · Cited by 492
Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., & Di Marzo, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.074 · Cited by 491
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 482
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.120 · Cited by 461
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
The Pharmacologic and Clinical Effects of Medical Cannabis
Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Etiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Wallace, M. J., Blair, R. E., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051920 · Cited by 393
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C., Petzold, A., Thompson, A. J., Giovannoni, G., et al. (2003) · Brain · doi:10.1093/brain/awg224 · Cited by 342
Molecular Mechanism of TRP Channels
Zheng, J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120001 · Cited by 335
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.12.010 · Cited by 327
Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312
Stevens, C. J., Murphy, C., Roberts, R., Lucas, L., Silva, F., & Fuller, D. Q. (2016) · The Holocene · doi:10.1177/0959683616650268 · Cited by 303
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
Ahluwalia, J., Urban, L., Capogna, M., Bevan, S., & Nagy, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00389-4 · Cited by 302
Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
Eubanks, L. M., Rogers, C. J., Beuscher, Koob, G. F., Olson, A. J., Dickerson, T. J., & Janda, K. D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060066m · Cited by 268
Philpott, H. T., O'Brien, M., & McDougall, J. J. (2017) · Pain · doi:10.1097/j.pain.0000000000001052 · Cited by 268
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
Jones, N. A., Glyn, S. E., Akiyama, S., Hill, T. D. M., Hill, A. J., Weston, S. E., Burnett, M. D. A., Yamasaki, Y., Stephens, G. J., Whalley, B. J., et al. (2012) · Seizure · doi:10.1016/j.seizure.2012.03.001 · Cited by 248
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
Howlett, A. C., & Mukhopadhyay, S. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00187-0 · Cited by 229
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
Wallace, M. J., Wiley, J. L., Martin, B. R., & DeLorenzo, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01243-2 · Cited by 226
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Iskedjian, M., Bereza, B., Gordon, A., Piwko, C., & Einarson, T. R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x158066 · Cited by 216
Sylantyev, S., Jensen, T. P., Ross, R. A., & Rusakov, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211204110 · Cited by 213
Centonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardi, G., Bernardini, S., et al. (2007) · Brain · doi:10.1093/brain/awm160 · Cited by 207
Wallace, M. J., Martin, B. R., & DeLorenzo, R. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02331-2 · Cited by 206
Pharmacokinetics of Cannabinoids
McGilveray, I. J. (2005) · Pain Research and Management · doi:10.1155/2005/242516 · Cited by 202
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Jordan, C. J., & Xi, Z.-X. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 197
Jiang, H.-E., Li, X., Zhao, Y.-X., Ferguson, D. K., Hueber, F., Bera, S., Wang, Y.-F., Zhao, L.-C., Liu, C.-J., & Li, C.-S. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.05.034 · Cited by 195
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.013 · Cited by 187
Hill, T. D. M., Cascio, M., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 187
Sense and specificity: a molecular identity for nociceptors
Caterina, M. J., & Julius, D. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00009-4 · Cited by 185
Aggarwal, P., Carter, M., Sullivan, M., ZumBrunnen, P., Morrill, P., & Mayer, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0016 · Cited by 184
Fitzcharles, M., Baerwald, C., Ablin, J. N., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0084-3 · Cited by 178
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Neuromodulatory functions of the endocannabinoid system.
Marsicano, G., & Lutz, B. (2006) · PubMed · Cited by 172
Cannabidivarin is anticonvulsant in mouse and rat
Hill, A., Mercier, M., Hill, T., Glyn, S., Jones, N., Yamasaki, Y., Futamura, T., Duncan, M., Stott, C., Stephens, G., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02207.x · Cited by 172
Wade, D. T., Collin, C., Stott, C. G., & Duncombe, P. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510367462 · Cited by 168
Characterization of the absorption phase of marijuana smoking
Huestis, M. A., Sampson, A. H., Holicky, B. J., Henningfield, J. E., & Cone, E. J. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.100 · Cited by 164
NGF Up-regulates TRPA1: Implications for Orofacial Pain
Diogenes, A., Akopian, A. N., & Hargreaves, K. M. (2007) · Journal of Dental Research · doi:10.1177/154405910708600612 · Cited by 163
Patwardhan, A. M., Jeske, N. A., Price, T. J., Gamper, N., Akopian, A. N., & Hargreaves, K. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603861103 · Cited by 161
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159
Nucleotide sequence of a human cannabinoid receptor cDNA
Gérard, C., Mollereau, C., Vassart, G., & Parmentier, M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.7142 · Cited by 152
Hausman‐Kedem, M., Menascu, S., & Kramer, U. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.03.013 · Cited by 149
Emerging roles for endocannabinoids in long‐term synaptic plasticity
Gerdeman, G. L., & Lovinger, D. M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705466 · Cited by 144
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
Akopian, A. N., Ruparel, N. B., Patwardhan, A. M., & Hargreaves, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1565-06.2008 · Cited by 142
Intravenous Injection in Man of Δ 9 -Tetrahydrocannabinol and 11-OH-Δ 9 -Tetrahydrocannabinol
Perez‐Reyes, M., Timmons, M. C., Lipton, M. A., Davis, K. H., & Wall, M. E. (1972) · Science · doi:10.1126/science.177.4049.633 · Cited by 133
Huestis, M. A., Mitchell, J. M., & Cone, E. J. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.441 · Cited by 132
Cannabis and epilepsy: An ancient treatment returns to the fore
Russo, E. B. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.09.040 · Cited by 129
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide
Milton, N. G. N. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00936-9 · Cited by 125
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s
Friedman, D. J., & Sirven, J. I. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.033 · Cited by 122
Lakhan, S. E., & Rowland, M. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-59 · Cited by 120
Cannabinoids in Pain Management and Palliative Medicine
Häuser, W., Fitzcharles, M., Radbruch, L., & Petzke, F. W. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0627 · Cited by 117
Plasma endocannabinoid levels in multiple sclerosis
Jean-Gilles, L., Feng, S., Tench, C. R., Chapman, V., Kendall, D. A., Barrett, D. A., & Constantinescu, C. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.021 · Cited by 100
Fitzcharles, M., Ste‐Marie, P. A., Häuser, W., Clauw, D. J., Jamal, S., Karsh, J., Landry, T., LECLERCQ, S. A., McDougall, J. J., Shir, Y., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22727 · Cited by 100
de Vries, M., van Rijckevorsel, D. C., Vissers, K. C. P., Wilder‐Smith, O. H. G., & van Goor, H. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.09.147 · Cited by 100
Inhibition of transient receptor potential A1 channel by phosphatidylinositol-4,5-bisphosphate
Kim, D., Cavanaugh, E. J., & Simkin, D. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2008 · Cited by 99
Diógenes, M. J., Assaife‐Lopes, N., Pinto‐Duarte, A., Ribeiro, J. A., & Sebastião, A. M. (2007) · Hippocampus · doi:10.1002/hipo.20294 · Cited by 96
Guggenhuber, S., Monory, K., Lutz, B., & Klugmann, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015707 · Cited by 93
Role of the endocannabinoid system in Alzheimer's disease: New perspectives
Pazos, M. R., Núñez, E., Benito, C., Tolón, R. M., & Romero, J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.03.026 · Cited by 88
Hesdorffer, D. C., Beck, V., Begley, C. E., Bishop, M. L., Cushner‐Weinstein, S., Holmes, G. L., Shafer, P. O., Sirven, J. I., & AUSTIN, J. K. (2013) · Epilepsia · doi:10.1111/epi.12056 · Cited by 73
Nahas, G. G., Frick, H. C., Lattimer, J. K., Latour, C., & Harvey, D. J. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.369 · Cited by 64
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Taglialatela, M., Barrese, Miceli, Soldovieri, Ambrosino, Iannotti, & Cilio (2010) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s15369 · Cited by 56
Brents, L. K., Zimmerman, S. M., Saffell, A., Prather, P. L., & Fantegrossi, W. E. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206003 · Cited by 56
Marijuana Smoking: Factors That Influence the Bioavailability of Tetrahydrocannabinol
Perez‐Reyes, M. (1990) · PsycEXTRA Dataset · doi:10.1037/e496372006-005 · Cited by 52
Łuszczki, J. J., Andres‐Mach, M., Barcicka-Kłosowska, B., Florek-Łuszczki, M., Haratym-Maj, A., & Czuczwar, S. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.001 · Cited by 38
Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie
Volz, M. S., Siegmund, B., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0087-0 · Cited by 33
The (Endo)Cannabinoid System in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Centonze, D., Rossi, S., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82009-5 · Cited by 32
Third International Congress on Epilepsy, Brain and Mind: Part 1
Korczyn, A. D., Schachter, S. C., Amlerová, J., Bialer, M., Boas, W. V. E., Brázdil, M., Brodtkorb, E., Engel, J., Gotman, J., Komárek, V., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.06.044 · Cited by 16
Third International Congress on Epilepsy, Brain, and Mind: Part 2
Rektor, I., Schachter, S. C., Arya, R., Arzy, S., Braakman, H. M. H., Brodie, M. J., Brugger, P., Chang, B. S., Guekht, A. B., Hermann, B. P., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.07.014 · Cited by 11
Cited by
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Legare, C. A., Raup-Konsavage, W. M., & Vrana, K. E. (2022) · Pharmacology · doi:10.1159/000521683 · Cited by 275
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Gagné, V., Merindol, N., Boucher, R., Boucher, N., & Desgagné-Penix, I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1465136 · Cited by 19
Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection—A Narrative Review
Carter, C., Laviolette, L., Bietar, B., Zhou, J., & Lehmann, C. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040196 · Cited by 13
Cannflavins isolated from Cannabis sativa impede Caenorhabditis elegans response to noxious heat
Lahaise, M., Boujenoui, F., & Beaudry, F. (2024) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-023-02621-3 · Cited by 6
Metadata
- Authors
- Amin, M. R., & Ali, D. W.
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer International Publishing
- Published
- 2019
- Volume
- 1162
- Pages
- 151-165
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- OpenAlex
- W2964129888
- Cited by
- 278
- References
- 99
- FWCI
- 61.64
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.